Carcinogenic products and regions of incidence

List of Classifications by cancer sites with sufficient or limited evidence in humans, Volumes 1 to 124 ^a

Cancer site

Carcinogenic agents with sufficient evidence in humans

Agents with limited evidence in humans

products

Styrene

Teniposide

2,3,7,8-Tetrachlorodibenzo-

para-dioxin

Tobacco smoking (childhood leukaemia in smokers’ children)

Trichloroethylene

Multiple or unspeci

fied sites

Multiple sites (unspecified)

Cyclosporine

Fission products, including strontium-90

X-radiation, gamma-radiation (exposure in utero)

Chlorophenoxy herbicides Plutonium

All cancer sites (combined)

2,3,7,8-Tetrachlorodibenzo-para-dioxin

^a This table does not include factors not covered in the IARC Monographs, notably genetic traits, reproductive status, and some nutritional factors.

^b For benzene, the evidence in humans is sufficient for acute non-lymphocytic leukaemia, including acute myeloid leukaemia; and the evidence in humans is limited for non-Hodgkin lymphoma, chronic lymphoid leukaemia, multiple myeloma, chronic myeloid leukaemia, and acute myeloid leukaemia in children

Adapted from Table 4 in Cogliano et al. (2011) available at:

http://inci.oxfordiournals.org/content/early/2011/12/11/inci.dir483.short?rss=1